Probing Lipid Rafts with Proximity Imaging: Actions of Proatherogenic Stimuli.
From: Department of Medicine, New York Medical Center, Valhalla, NY 10595, USA.
American journal of physiology. Heart and circulatory physiology
- Publish Date: Jun 2006
- ISSN: 0363-6135
- Volume: 290
- Issue: 6
- Pages: H2210-9
- Medium: Print
- Language: English
- Citation (JAMA): Patschan Susann, Li Hong, Brodsky Sergey, et al. Probing Lipid Rafts with Proximity Imaging: Actions of Proatherogenic Stimuli.. Am. J. Physiol. Heart Circ. Physiol. Jun 2006;290:H2210-9
Abstract
Glycosylphosphatidylinositol (GPI)-anchored proteins have been shown to cluster in microdomains enriched in glycosphingolipids and cholesterol and represent a relatively selective marker of lipid rafts. In recent years, several attempts have been made to use fluorescent probes to nondisruptively label these domains in living cells. Here, we have transfected endothelial cells with a GPI-anchored thermotolerant green fluorescent protein (ttGFP) to show colocalization of this fluoroprobe with another marker of lipid rafts, urokinase-type plasminogen activator receptor-1. ttGFP was used to quantify the cell surface area occupied by lipid rafts and to examine the effect of various proatherogenic signals on lipid rafts. Exposure of endothelial cells to asymmetric dimethylarginine and oxidized LDL (oxLDL), as well as oxidant stress, reduced the cell surface area occupied by lipid rafts. Next, the property of ttGFP to undergo a shift in absorbance depending on the clustering of these molecules was utilized to perform proximity imaging (PRIM). PRIM showed that nitric oxide (NO) increased the distance between GPI-anchored ttGFP molecules clustered in lipid-rich microdomains. This “unclustering” of GPI-anchored ttGFP was not reproduced by prooxidant signals and was due to reduction in membrane-cytoskeletal constraints on the lipid rafts. These findings suggested that two fundamentally different mechanisms modulate lipid rafts: 1) substance regulation of lipid rafts involving modification of cholesterol and sphingolipids and 2) structural regulation of lipid rafts through disruption of membrane-cytoskeletal interactions, switching off the spatial confinement of lipid rafts.
Mesh Headings (Keywords): Animals, Anticholesteremic Agents, Atherosclerosis, Cell Line, Cholesterol, LDL, Cytoskeleton, Endothelial Cells, Fluorescent Antibody Technique, Genetic Vectors, Glycosylphosphatidylinositols, Green Fluorescent Proteins, Humans, Immunohistochemistry, Membrane Microdomains, Mice, Microscopy, Fluorescence, Nitric Oxide, Nitric Oxide Donors, Nitric Oxide Synthase Type III, Reactive Oxygen Species, Superoxides, Transfection
Check for Full Text / PubMed Unique Identifier (PMID): 16361365
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.